Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $2.64 billion. The enterprise value is $2.34 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 43.02 million shares outstanding. The number of shares has increased by 10.54% in one year.
| Current Share Class | 43.02M |
| Shares Outstanding | 43.02M |
| Shares Change (YoY) | +10.54% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 3.25% |
| Owned by Institutions (%) | 85.68% |
| Float | 32.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.93 |
| Forward PS | 3.56 |
| PB Ratio | 7.56 |
| P/TBV Ratio | 7.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.74 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.74 |
Financial Efficiency
Return on equity (ROE) is -13.96% and return on invested capital (ROIC) is -7.45%.
| Return on Equity (ROE) | -13.96% |
| Return on Assets (ROA) | -5.87% |
| Return on Invested Capital (ROIC) | -7.45% |
| Return on Capital Employed (ROCE) | -11.61% |
| Weighted Average Cost of Capital (WACC) | 7.17% |
| Revenue Per Employee | $1.45M |
| Profits Per Employee | -$130,446 |
| Employee Count | 370 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 29.44 |
Taxes
In the past 12 months, TARS has paid $4.41 million in taxes.
| Income Tax | 4.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.25% in the last 52 weeks. The beta is 0.53, so TARS's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +40.25% |
| 50-Day Moving Average | 66.28 |
| 200-Day Moving Average | 67.40 |
| Relative Strength Index (RSI) | 42.23 |
| Average Volume (20 Days) | 757,000 |
Short Selling Information
The latest short interest is 4.82 million, so 11.20% of the outstanding shares have been sold short.
| Short Interest | 4.82M |
| Short Previous Month | 4.56M |
| Short % of Shares Out | 11.20% |
| Short % of Float | 15.00% |
| Short Ratio (days to cover) | 9.38 |
Income Statement
In the last 12 months, TARS had revenue of $535.08 million and -$48.27 million in losses. Loss per share was -$1.13.
| Revenue | 535.08M |
| Gross Profit | 427.95M |
| Operating Income | -50.81M |
| Pretax Income | -43.85M |
| Net Income | -48.27M |
| EBITDA | -49.02M |
| EBIT | -50.81M |
| Loss Per Share | -$1.13 |
Full Income StatementBalance Sheet
The company has $388.73 million in cash and $88.68 million in debt, with a net cash position of $300.06 million or $6.97 per share.
| Cash & Cash Equivalents | 388.73M |
| Total Debt | 88.68M |
| Net Cash | 300.06M |
| Net Cash Per Share | $6.97 |
| Equity (Book Value) | 348.95M |
| Book Value Per Share | 8.11 |
| Working Capital | 393.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.45 million and capital expenditures -$15.09 million, giving a free cash flow of -$31.54 million.
| Operating Cash Flow | -16.45M |
| Capital Expenditures | -15.09M |
| Depreciation & Amortization | 1.79M |
| Net Borrowing | n/a |
| Free Cash Flow | -31.54M |
| FCF Per Share | -$0.73 |
Full Cash Flow StatementMargins
Gross margin is 79.98%, with operating and profit margins of -9.50% and -9.02%.
| Gross Margin | 79.98% |
| Operating Margin | -9.50% |
| Pretax Margin | -8.20% |
| Profit Margin | -9.02% |
| EBITDA Margin | -9.16% |
| EBIT Margin | -9.50% |
| FCF Margin | n/a |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.54% |
| Shareholder Yield | -10.54% |
| Earnings Yield | -1.83% |
| FCF Yield | -1.20% |
Analyst Forecast
The average price target for TARS is $94.22, which is 53.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.22 |
| Price Target Difference | 53.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 18.14% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 6.92 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.92 |
| Piotroski F-Score | 3 |
